Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-019283
Filing Date
2019-04-11
Accepted
2019-04-11 16:05:54
Documents
1
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv518741_3.html 3  
1 OWNERSHIP DOCUMENT tv518741_3.xml 3 2762
  Complete submission text file 0001144204-19-019283.txt   4440
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address
Siffert Joao MD (Reporting) CIK: 0001534986 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 19743835